Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Noosfera

Noosfera artwork

Noosfera 206. ADN que se copia y se repara | Alicia del Prado

Jul 19, 202458 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Hablemos sobre ADN, pero hablemos bien. Normalmente se habla de genérica en general, sin dar detalles, como si funcionara por magia, cortando y juntando letras cual editor de texto. La realidad es más compleja y vamos a desgranar punto por punto. Para hablar de ello tenemos con nosotros a Alicia del Prado, que es Licenciada en Bioquímica, Máster en Biología Molecular y Celular y Doctorado en Bioquímica, Biología Molecular, Biotecnología y Biomedicina por la UAM. Desde 2009 trabaja en el Centro de Biología Molecular Severo Ochoa y en la Facultad de Enfermería y Fisioterapia 'Salus Infirmorum' de la Universidad Pontificia de Salamanca. Un podcast de Diario La Razón, dirigido y presentado por Ignacio Crespo y producido por https://lafabricadepodcast.com

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

He' s not expecting the Reason Science Podcast. I' ve been scissoring these DNA fragments for hours, remembering from here, sticking around that it' s what DNA does in the end. To change, no, well, I' m about to finish my creation a couple more cuts and now but

what is this. Anyway, my name is Ignacio Crespo and this is a sphere the Podcast of Reason Science. Today we are talking again about genetics and at an intermediate point between superspecialization and the absolute generality of genetics. Point then let' s talk, specifically with Malicia del prado, who is a graduate in biochemistry, master' s degree in molecular and cellular biology and doctorate in

biochemistry, molecular biology, biotechnology and biomedicine by the OONG since two thousand nine works in the Severo Ochoa molecular biology center and in the Faculty of Nursing and Physiotherapy Salus infier Morum of the Pontific University of Salamanca. Thank you so much for being with us, Alicia, thank you very much. Ignatia delighted. Spend the afternoon with you. I loved it because I also know that I ' ve made it difficult to record. This is one of those programs that I think when I wrote it because I get there on the drive it was one hundred and eighty- two and now we' re already by two hundred

and six. I mean, something' s happened one thing and the other, but the reality is we' re here. Let' s talk about genetics and I' d like to know when you decided that your life was going to be that, it was going to be researching that, because the truth is that I' ve never had a clear vocation. It took me a long time to decide what he' s studying and in the end I decided to start biology. Then I finished my bachelor' s degree in biochemistry and I think that every time I got to know a little more about the world of science, then the world of research, I was passionate a little

bit more, a little more, and I think that still happens to me a day after day, that I think that passion for science and research is growing in me. Every time I discover new things. I was very lucky because when I was finishing my career, I met Dr Margarita Salas and offered to start my doctoral thesis in her laboratory. I think that has also been one of the things that most marked my life and career and from there, nothing. I have continued to investigate and here we are still investigating and with

a lot of passion you still comment that you still did not have a clear vocation. And I want to ask you if you were still clear that you weren' t going to be a boot biologist, because the robe is clear and in your trajectory. That' s right, that' s right. I have to say it. I remember that even in the early years of the race, when we were hiking, I didn' t like anything and I saw super excited fellows because we were going one day to the country and for me it was like uff you wanted to pipe back in the lab. In fact, when we were in the lab, there were colleagues who felt super locked up. I was in the lab and I was thinking, so

if we' re here super comfortable with the pieces and you say you' re still amazed by science. I want to ask you if there' s any recent concept you' ve discovered reading papers, not you in the lab anymore, but reading papers that I left you with that sense of wow. This keeps surprising me. I think it happens to me all the time, because every time constantly, that is, every time I read something new, I keep thinking all the things that I have left to know that I think a good science thing that you never touched done that there' s not a day that any of us already in the lab and let' s say is

already done. We have nothing else to investigate, but we have nothing else to investigate or what new things we can ask ourselves. There' s always a new question, there' s always something new and I' m always surprised by everything other people do, that that' s very nice too. And then, before passing the questions of the listeners and the reason for what you just said, I have to ask you a question and imagine that you see a genius in front of you that will coexist, grant no longer three wishes, one desire and that desire may be to know everything you would discard

you would prefer to keep that space to continue discovering beyond simply knowing that I am so curious that I would say yes, that I want to know everything clear, but you have fixia with that. Then it would be even better to let us know the whole rise. I think that' s impossible, that would be crazy. Of course, I do keep covering little by little, but it is true that I think we have so many things left to know about me, at least I do want to know a lot, a lot, a lot more. But of course, we' ll all know a little bit more because a little bit or a lot. I' m

going to be ambitious, because we' re going to talk about genetics just around the corner from advertising. We' ll be right back. We' re back. Everything works here as usual. It doesn' t change, never anything. Anosphere is something practically static and we carry no matter what programs they are that have the same structure. We launched a call for questions on social networks. You, who are listening to us on the other side, if you have been watching the networks, have left your questions and here we collect them and answer the ones we can. The first question of all is

from Luis Scannet, who says good morning, what does DNA amplification mean, because it is one of the key concepts that we are going to be working on true during the program. That' s good, because the amplification of the view even if it seems a bit complex concept, is very simple. It is simply that from a very small amount of that DNA, from that genetic material, we are able to obtain a great deal. So, well, now we' ll talk a little bit more about applications to understand why we want to amplify DNA. But many processes that we know are day to

day need to start with an amplification of DNA. VALE is a rather intuitive concept. Then amplification is to amplify the amount. If you had two, now you have two hundred, for example, effectively, to put absurd numbers, but well, to put them much more from truly small amounts. Tell us a little bit about everything. On this, imagine that we are talking about real quantities, you take, a sample of whatever it is and you are going to have to amplify it, because there was little of how much

you can spend, because we are talking, for example, in the laboratory that with one of the polymerases with which we have worked, that was the polymerase of the f twenty- nine fago, which is with which margarita Salas. He' s been investigating for many years. He' s been researching this in his lab for over fifty years from some side, even a nanogram. I don' t know if people imagine how small that is, but we' re talking about raising the least new one, that is, we put zero, zero, zero, zero, one found the word that we

need to put three more zeros. No and it' s milli micronanopicocento That ' s what, it' s a lot of zeros from the small amounts. We are unable to get even micronamodmia others. It' s a barbarity, it' s true of totality. It' s impressive and you said a word that I want us to delve into it and make it clear that it means it' s polymerase. And besides, it is worth José Fernando ' s question for this, because José Fernando, ahead of time, tells us what and what the polymers are for what his study has brought us. Two questions. If you want, let' s go first with the first

one and then with the one who contributed us. That' s perfect. Well, polymerases are proteins, really fascinating enzymes. I would say without a doubt that they are my favorite protein. When we talk about above, we say that they are proteins, that they are able to have a catalytic activity, that is, that they are able to catalyze a reaction, to make it happen faster. And in the question maybe it' s but what reaction they give you what a polymerase does. Of course, what you' re going to do is copy the DNA, copy that genetic material. So we can say to make it very simple, that they' re like molecular photocopiers.

I don' t know if everyone understands that it' s the concept of DNA that we' ve started talking about, as well as maybe very direct. And I don' t know if everyone knows that he' s listening to us from home, that' s that DNA, that genetic material. People are thinking they' re letters. So you have to start explaining that they are not, because we can say that they are four letters, not that there are four nucleotides, but only with those four nucleotiums, which are ACTG you write all that we are. So all of our genetic material is made up of this DNA, which forms that typical double- lice structure

that you' ve probably heard about that Watson and Cried discovered with the help of Rosalline Frankling, and that DNA in what it does is hide all that we are what happens to that genetic matter, because it' s in all our cells and that every time our cells have to be divided they have to replicate. What you have to do is copy that genetic material. That' s why these polymerases are there that make that role so fundamental that it' s being able to copy all that genetic material before the cell splits. This may seem like a simple process, but it really is very complex. First

because we have a lot of genetic material. I mean. One of the things that we always find surprising when we tell it is that if we take the genetic material out of all our cells and stretch it out, it would travel far away from here, to the moon thousands of times that really is crazy. So each of those cells has to be able to copy that material and, in addition to doing it right, that maybe this is the most complicated part, they have to do it fast and do it right. That ' s what we call faithful ones, that they don' t make a mistake in messing with those letters, those nucleotides we talked about before. This

is what replicative polymerases do, as is polymers, to say twenty- nine in which we spoke before, after other polymerases that are sometimes replicative, are more specialized in repair. I' ve been working more in the lab lately with these polymerases and their role is to try to solve when there' s a problem with this genetic material. Imagine that there has been an external or internal agent that has damaged it that there is a break in that genetic material. So, there we have other repair polymers that are going to take care of trying to keep that cell viable and to solve that little problem that has

come up with its genetic material. And well, then he takes care of how to recover the initial structure and can make mistakes. I understand because sometimes, well, the polyvecious replicatives make very few mistakes, because sometimes this can become a very big problem and you generate a mutation. Sometimes they do it in very small percentages and they have an activity, in addition to this, of polymerization that is called exo nucleas or corrector of errors, which is able to detect when it has been wrong and try to solve it only the replicative

polymerases, the ones of repair are already going to find a really bad situation. For example, one of the most serious is that double me breaks, that there is a break in this double chain. So there they can afford to make some mistake in order to solve that big problem that can put the viability of that cell at risk. Sure. The second question was that he has given us his study. Well, actually, a lot of things. I' m passionate about basic research. That means that for me only to

investigate by knowing it seems sufficient, that is, to be able to ask us how a process works and to know it. It seems to me already sufficient advantage and sufficient positive reinforcement to investigate something in this podcast we totally agree that sometimes it is difficult to explain to people because when you tell them what you' re investigating, the first thing they ask you is but for what, and sometimes it' s a little hard to explain for what. Basic research has very good things. The first thing that helps us advance in knowledge. That' s fundamental. When we know something, we can understand,

that that already seems fantastic to me, and besides, we can control it. And that' s very important, because by doing a basic research you can get apps that a priori, because we didn' t think about what ' s going to happen. Then we investigate something in the lab and even if we ourselves are not going to apply them for the best, tomorrow, a person reads an article of ours and is inspired and who knows, because this might be useful for this application. And that' s the nice part that we' re each putting as our bit of sand so things can get better and so that we get to know more and more things. We study

in the laboratory processes that are very complicated, such as a replication that is very difficult to study in organisms like us. What we do is we use model organisms that are much more basic, much simpler. So, from there we put that bit of sand so that these results can be extrapolated to more complicated organisms, such as acariot cells like our cells, and so, for example, in replication an application that has very clear is cancer, for example, when there is a problem and a cell replicates more than it should, this pathology or some mutations can arise. Therefore, it is essential that we

do that research so that we can then make more applications. There are many other applications of technology, but maybe we leave it a little bit for later, when we talk about why we amplify all that genetic material, all that great adn. I also have a question because you talked about polymerases in plurals. You said even two large groups, but within those groups there are more types of polymerases, that is, my polymerases are the same as those that a tapir or bacteria may have. There are polymerase families, so one thing

we do is sort them out. Second function they have, for example, many of the replicatives are in a family that we talk about the family, which is like the quariot type. Many of those that are repair belong to the X family or the family there, that is, that there are different families that we can still classify with respect to whether or not they are similar. Perhaps the good part is that we can take all the polymerases of any organism and those that resemble each other that belong to the same family. What we can do is line up, which is how nice you have. That

which we see that the regions that are most important are preserved throughout all evolution, from a virus like the one we study in the laboratory to a polymerase of ours. So, the essential parts, such as, for example, a part we call the catalytic aspartites, which are necessary for the reaction to occur, are in highly conserved areas and there are parts of this sequence that we call domains, which are also preserved in many of them throughout evolution. Another question I want to ask you to better understand what this protagonist is like,

which is the polymerase that we both talk about or the polymerases, is about its size, because proteins have very variable sizes. In fact, DNA in a somewhat huge way and there are others that are very small within the world of proteins, s where we place it. Well, there' s a little bit of everything also depends on the organism we' re talking about, for example, ours that we' ve been working with for so long in the lab, especially since with the organic docetrara salts. Polymers, to say antinine, have five hundred seventy- five amino acids, which I don ' t know if listeners understand the concept of amino acid well or where we

saw it, because in this genetic material, what we have is the sequence of all the proteins that we' re going to need in our cells. So what we' re going to do is that that sequence of nucleotia corresponds to an amino sequence and every three nucleotia we can have an aminovation, so the proteins are formed by these aminovacides. So we have very different sizes and also some even form complexes to be able to fulfill their mission well. They

don' t work on them alone, they always have hobbies that help them do that mission properly, and that happens to many polymerases, especially in organisms like us, in which they are much more complex. Well, now that we know a little bit about the main actor of these repairs, I was going to tell the telemers that we' ll talk about plain polybrasses. Indeed, we have a question of arming ora that already goes a little bit more to the general says what the non- coding regions of the genome are for

here we should explain a little bit what it is about non- coding regions and why it has so much controversy behind it, For the coding part is what we said, that those nucleotiums that we have in our genetic material in DNA give rise to proteins. So the part of the non- coding regions is that it has been seen that a very large amount of our genetic material is not directly coding for a protein. It' s not going to lead directly to a protein. It' s just that if you had some kind of dictionary that would tell you this achievement of nucleotiums between DNA letters quotes,

it' s this protein that would be those super functional molecules that it looks like people all in the organism you' re going to look for that sequence of the others that you' ve found in DNA and it' s not so much the dictionary that, in a way, says this is nothing. This doesn' t mean. But it has a twist, because at first it was thought that those regions were called, even Trash DNA. They were thought to be of no use at all and, moreover, in a very high percentage. But every time research is being done it is discovered that they are very important regions for regulation. What does this mean to regulate because to

me one thing that always surprised me and that when you talk to many people it seems curious is that the genetic information in all our cells is exactly the same, and this seems very obvious. But then the tumbulas of our body are very different, that is, we look at the shape that has, for example, a neuron, the one that has a cell of our heart or our eye or finger of the hand, has nothing to do with them. So, if they have the same genetic information, why are they so different. Well, for the proteins they express. This means that each of these cells, at a certain point in time, expresses or encodes certain areas

of that genetic material for proteins and others does not. Other proteins express us in that cell, so the proteins that express in which it is not what makes those cells so different from each other. What has been seen is that in this very encoding area the genome does, there are many regulatory regions and that allows those genes to be transcribed or not to proteins. The transcript I don' t know if you' ve heard of the central dogma of molecular biology, we go over it. Come on, so if we' ve

talked about replication, it' s like the first part of the dogmas that cells always have as genetic material that DNA and that they' re able to copy it, to duplicate it. It' s the replication. But then, to give rise to proteins, you have to first transcribe it, that is, that that DNA passes to RN and then the next step would be to translate it that whether it' s RM goes directly to that protein, which is the one that' s going to fulfill that function. And we have the whole process, from the in- quota information that' s in that DNA to that that' s supposed to express how you' re saying

even those proteins that are going to finally fulfill that function. In our body, I find it super interesting. This that you comment that before it was called ne garbage, because during this time I no longer say when I studied the medical career, but later divulging, I have found how the public has become outraged. I look at the public because it' s called an adn and I' ve seen some geneticists defend the term within a perspective. I understand that historical and that even though much is regulatory, there is another one that we still don' t know exactly what to do at all. No, but I am sure that in the coming years it is necessary to begin

to discover the function that each of those small pieces has that we currently do not know what they serve. That' s very interesting. It' s a bit of an approach to whether it' s there is something not or we assume that in principle there shouldn' t be a lot of space in DNA that isn' t doing any function for economics or what. But clearly it has to have an essential function if it is there and if it has been kept along the dul that. That does give us the signal that if it has been maintained and has not been lost, it is because even if we do not know it, we have not been able today to know exactly

when it works. No doubt she has to have tea. I' m going to ask another question knowing you just answered this. I don' t mean to go catch' cause I can' t catch you. That, of course, is more than anything, because I have in my head things that I suppose I publish too and I want to raise it all when we have things about because what is being researched in genetics from time to time you say hear, because it has been found that at some point in our history, as a species, a virus left part of its genetic material in our DNA and has remained there. This would also have a function or act in

some way in DNA. Or it could just be, because a vestige can have a function, that is. In the end we have to study one case per case. And it is clear that there are also viruses that are lysogenic, that is, when they infect a cell, they can integrate their genetic material, the genetic material of the cell to create something as much simpler. For example, there are some bacteria that, if they have a lysogenic virus they are able to produce, that have to make that bacteria produce toxins and that produce a certain characteristic when it infects us that is not going to

happen. If that virus isn' t there, then clearly everything ends up having its meaning and its why. When you comment on this, I think a lot about diseases like Huntington, which is by repeating triplets. I mean, you repeat a series of sequences of these that we' re commenting on at one point in the DNA and one might say good are repeated. I don' t care about the number of times they repeat themselves always functioning the same, but it is known that there is a relationship between how many repeat themselves and how soon the disease appears, etcetera, etcetera. I mean,

even in that case redundancy seems to have an effect. You know that sometimes we think that the excess of something is going to be good and clearly it can' t be very bad. Even as we return to some pathologies, as I am given an excess of genetic material does not have to be good. They are in their rightful measure and we will return to the questions of the listeners, of course. But speaking of the excess, when I imagine quantities like the ones you said before I put all the genetic material in line and go to the moon and come back thousands of times I say oysters to

me sometimes it' s hard to move papers on my table without losing them and they turn around and I have a lot more space. And I also think about what' s typical about wires. You put a headset in your pocket and just as soon as you move it without believing that you get entangled in some way, those molecular mechanisms inside the nucleus of the cells are able to move, deploy, cut, bend, modify the DNA without it being scrambled, lost and happen practically those three how it is possible and organized as well, because note that I always think that, even though the cell has

a lot of molecules inside when, for example, these proteins have to run away from DNA, what they have is not a very big aginity for it. That means they' re going to feel a very strong attraction and they ' re going to find him wherever he is, they' re going to go look for him, they' re going to find him and they' re going to do their job. It' s a nice part, I mean, maybe I' m trying to figure out how things are going. When we are studying how any process works, we have to think like a miniature world, like a small factory in which everything is working with a perfect gear. And maybe it' s a way we can try to understand a

little better month how life works inside of us, without us noticing. We have a pigeon question that occasionally leaves us with questions and she seems very excited about this one. Says the following ufff temazo. I' m reading it as I' m afraid. I have a feeling that my mind can' t understand how molecules move to that level, which is a little what you ' re telling us. It says about the thirty seconds, because the basis is how detail works and you can tell us a little bit what this is and add my six- hour pcrs leave me time to think about the human

and the divine. Yes, I mean, clearly it' s a little bit of what we were talking about before, that we have to think of a small factory at the molecular level, where everything has to function in a millimetred way. And also when he talks about the speed at which he can polymerize one of these proteins, what we have to think, which is the amount of genetic material we have, is very large, as we talked about before. Therefore, you cannot be incorporating a nucleotide or one of these letters and two minutes, three hours and then the next. That' s incompatible with life. So when we talk about it, it' s what they

do that these reactions have to be fast enough to allow a biological process that every time you do it. If I had to split, we' d have to wait for a polymer to work for hours and hours and hours and hours. That couldn' t work. Really. They have to be very fast, very efficient when they are needed. And name here the pc that is polymerase chain reaction. Then I want to ask you precisely why it takes her six hours. And indeed, the PCRS can be very long, because that time difference, because we' re doing it on a much higher scale

than the cells do. Either there are people who don' t act here or the PCR, which has several cycles. That means that the same reaction is letting it work several times, for example, twenty- five or thirty times. So I' m not very convinced if you want me to explain how the RCP works. But in the end, it seems interesting to me because in the end the RCPs sound like the pandemic. People kept repeating it to them. I don' t know if you remember this. I think I' ve already said it here once in a sphere that when you started talking, the PCR media said proteind makes reactive that, in fact, immedicity

also exists and has the same. It' s absolute, it' s exact, it' s totally different. But instead, they started from that chaos and that ignorance and in the end their use was normalized and people believed that the pcrrerera the concrete test of that of the choir. So we' re talking about it, because the RCP is one thing that I think whoever entered a biology lab has done to get bored and that' s fundamental to scientific research. I mean, the first thing to say is that the PCR

is an amplification reaction, which is what we were talking about before, from very small amounts of genetic material, what we' re going to do is get a very large amount. So, for example, when we talk about how we can use it as a diagnostic method, for example, to detect coronavirus, what we' re going to do is we' re going to be able to amplify an area of the genetic material of this virus. In the case of coronavirus it is a little more complicated, because this virus does not have DNA as our cells have IRN. What that means is that there has to be a step of its own to make the feathers work where SRN

converts it into DNA, which is usually done in a PCR, because what we do is we seek to amplify a sequence. Specifically. Then they get like some oligonoculotides, some first ones, that is, a sequence that we designed in the lab to start it. From there. It' s not because the polymerases need a zone to start that we call as prime mer primer initiator, that is, an area where they' re going to grab to start using that other chain, how to mold and get that replication to occur.

So, with these nucleotia sologo that are designed, what we do is mark a particular area that we want to enlarge, what a phase this PCR is having, because it has so many cycles, because what we' re going to do is first, that that' s good, first, that that genetic material is deciphered, that is, that that double DNA chain stays in a simple chain. Then those oligonucleotides come together, that is, they provide the specific sequence so that we have designed where we want them to come together. And then, that' s when the polymerase comes in and starts

putting those nucleoties in and replicating. And this is what we do many times. That means that in each of the cycles we are getting more and more and more and more DNA. I remember when I gave people the results of the RCP. Many times they told him what cycle he was positive for and what the infection is. That, then, is that a person who has tested positive for coronavirus in a very early cycle, because what I mean is that their viral load was very large. I had a lot to do I had to do little amplification. That' s if we needed to do many cycles to do some amplification, because it' s telling us that the amount

of starting DNA was lower. I think if there' s a program to talk about PCR, it' s this one. So I' m going to ask you more questions, because I think it' s the right thing to realize that I' m not especially zal in the RCP. I like much more another method of amplification that we do in the lab, but if you have something, I want you to give me that too. But I ' m gonna ask you a question. Then we' re going to advertising and after advertising you tell me that it is how we' re going to put the hook. What I want to ask you is that you have described us super well and with details how this whole process works and in the end

we know if there is the DNA sequence that interests us. We have to design that sequence that we want it to be cople and I understand that if we are little horned and we make it very short, we say well, because I look for this sequence of four letters by pure chance. I' m gonna find that sequence at a lot of DNA sites, some of which I' m not interested in, but I do make it very long I ' m sure it' s a roll and it' s got other problems. How you decide what is the right length of what you are going to seek and forgive just so that we are all on the same page imagining that it was a book. If I want to look for a fragment of the

book as a pdf search engine, the typical thing we do. We need to look for not a single article, because the articles are going to be many, very similar, not two whole sentences that I may not remember what they were like. I need something balanced. You picked it out, that ' s all. I think you' ve made a very good simile about looking for an article or a certain area of a book, that is. We can talk about, for example, that book being all our genetic material, our entire genome, and what we want to amplify is imagine a specific gene that would be a brain page. So what we have to know first

is what we' re looking for, that is, what letters or what sequence we' re looking for. How it is said to add, because it is complicated, not only by length, but also because the PCR is becoming different temperatures. Then you try to get an optimal temperature at which that oligonuclotide that we have designed that first and bridle exactly with the area that we want. Depending on how this sequence is, you also have to keep in

mind up to what the letters are, that is, we, when we have the four nucleotiums, we have TC and G instan joined together just as strongly the A- T that the C- A- G then this changes the temperature to which they are going to join. That' s why you ' re trying to get it. There are even programs that help you set exactly what or then nucleotides you' re going to put and so we design if they' re a little bit bigger, they' re a little smaller,

also depending on this temperature to which they' re going to bind the DNA and make it the best and that' s very specific. Notice that if you eventually join anywhere, what you' re going to do is amplify in areas we don' t want. So that doesn' t have any specificity. It' s no use telling us if there' s what we ' re looking for. Then it would be a bad method, but you can' t make it so restrictive that it never meets. Then we have to play with a balance to design exactly the best oligonuclo. Uncle you need to make this pc RE work well. And sometimes with programs and sometimes I

understand that by trial and error you try it and say this has not been worth me. You even change temperatures. There are times when a PCR doesn ' t work well. One of the things we do in the lab is a temperature gradient to see exactly when it can work best. Of course it ' s the best way. You just said it and I' ve totally remembered the cookware conscience books. There is a lot that sometimes more than many times to face the problems of what temperature for this type of material that I want to cook makes you subralient with so imagine twenty eggs and so they have

exactly what they have to do. Yes, we' re going to the publicity and we come back with that question I promised to ask you, we ' ll be right back. We' re back and you were telling us that you' re not especially france the RCP, which may have dislocated many basic biothings. I want to make it clear that it' s not eagerness. I mean, it seems like a mind- blowing method, of course, but that we in the lab have worked more with another amplification method that I think has some features that make it a good competitor or that make it

special compared to the PCR. So, well, this method. What would allow us would be, for example, rather than just copying a page from that instruction book that we said before would allow us to copy the entire Book. That seems to me to be one of the fundamental advantages, that is, practical affections. We can use it to sequence a genomenter, to amplify a genomenter. Then I speak amplified, for example, one of the applications that can be done is to sequence it like this, to know exactly what

the letters are, what the code is for that whole gene. And, moreover, we can do it at a single temperature that pre us this also not knowing the sequence of what we want to amplify. We can amplify anything that there is without having to know that specific sequence, which is one of the things that is usually done with the PCR usually always, but we usually know a PCR, we know the sequence to be able to design its demands and amplify it and how it works. So this technique you' re talking about we' re going to name it and step it up, because this

amplification technique is based on the polymerase of the civic vacteriophagus of this sve twenty - nine virus that we were talking about, with which has worked margarita more than fifty years in laboratory, that well, I don' t know if everyone knows what a bacteriophage is. Let' s go with it. A materiophagus is a virus that is uncertain only bacteria. That means that we can work quietly with the laboratory and it won' t affect us, it won ' t do us any harm, because its polymerase. It' s been seen to have more properties than they totally do. That' s to make a really amazing biotechnology tool. And this allows those amplifications to be done as

we said before, and even knowing the sequence and allowing very, very large areas to be amplified. Then this later, when we have such a big amplification, we can use it as we said before, for example, to sequence a genome. That' s good, how long can this sequence of a genuenter take? We' re going to make human. I have to say it' s never a German sequence anymore. We amplify with the pragiras, but it won' t be something daily, not at all. In addition, it is somewhat more expensive but at present the techniques are developed in

such a way that something that was previously unthinkable, is done in the laboratories right now in a much more routine way, especially, for example, if we are talking about the diagnostic buds, of course how good, because we are already seeing there applications that we will then walk in them. But before that we have a question that I know follows in the basics, in what is all these foundational concepts that we are commenting on. Ramón does this to us and tells us how micro rnas studies are carried out to discover the potential flats. And here there' s already a lot of concept, first,

that it' s micro RNA, q RNA or RN that, in a way you' ve named it, but now it' s time to explain it and what the potential vials are So, if you want me to ask you about all that and then we go with Ramon' s question. First, IRN, because RN is what we were talking about before in the end, our genetic amatega is DNA. And what we' re going to do is that by that transcription process we' re going to pass it to RN that' s going to serve it to messenger IRN, because it' s actually that messenger or being midpoint between DNA and then protein. So, this

DNA is the one that' s then going to be translated to give rise to those proteins. So it' s that intermediate step between our genetic material and the proteins for which it' s encoding that genetic material. And, out of curiosity, for all of us to get an idea of what differences there are between DNA and RNA, because sometimes they tell us that it' s that it changes a letter, that DNA TINCTG and that RN has a place of tymine G. But we also drive DNA sink deoxyribonmpleic acid and yet

the RNA is has been nucleic rib, so there is another small chemical modification and that make them different and has even been different working with them in the laboratory. For example, in RN you like it much more easily than DNA. It' s more complicated to work with them in the lab, that this is one of the things that you insist a lot during the pandemic, because since vaccines are RNAs that put you in the cells, it says uy will stay there. Look. I' ve worked in the lab with RNA

TE I assure you, it' s absolutely paranoia. What you have to have to keep samples from getting contaminated is not spoiled. I assure you he won' t stay in RM, in your cell with absolute care. Yeah, yeah, yeah. I say this because, as is sometimes explained only by saying about the change of lyrics, this which you have commented seems super fundamental to me to understand why that step is made and that there are another series of characteristics that change and that are determinants. Yeah, and besides, clearly, then every protein is going to copy its own. Each protein has its function, i e, for example, a polymerase usually cannot go and

copy RN instead of DNA. That is, it changes the structure and also changes how we are going to work with it, not only in the laboratory, but also in our own cells. And the next thing I' m going to ask you then is that it' s a micro RN, because as its name indicates, it' s a much smaller RN and what' s been studied of them like me, I must say I don' t know much about this. I' m not an expert at all, but some of the things I' ve read is that it' s very important in regulatory processes. So, some of these microorders are going to be expressed

at a certain time and may have regulation functions. So, when we want to study them, we need to be very clear what exactly we are studying, know their sequence, and see what processes can be affected. So, according to that, we can look at what you' re doing in this case, this little tern messenger is maybe silencing the expression of dibu people. Then we can start putting and studying which applications can have that good. And the third question, in terms of terms, is what the potential targets are,

because, for example, some of the genes that we can silence with these Organese vouchers you know where we want it to act. What we' re working on is great, because now that we know what he wants. Ask Ramon more or less, let' s see what the answer is. I remember the question telling you how micro- rnea studies are carried out to discover potential pathways. I can' t tell you much about it and it does whatever you want. The truth is, I didn' t know how to tell you much more. I mean, that' s good for witnessing something, but I don' t want to get into much better than people.

One of the pieces that has already been degrading the terms and view, we have more questions that now they will also enter into something that people expected, because I think that a little while they have seen your résumé and knowing that besides, with daisies wings and such and there will be more questions here, and one of them that are very popular when talking about DNA is the subject of telomerase. So I want to ask you and hater and Ninja also because it tells us what became of the fashion of telomerases as a source of eternal youth, tell us a little, what they are and what happened media,

because it is true that the subject is super interesting we as in the end work with good paradises many simpler in the laboratory. I' ve never worked with them, but it' s a subject I' ve read about and I especially like it for all the potential it has and how interesting it can turn out. When we talk about our genetic material, we all know that what we have is chromosomes. That means that our genetic material is linear and in the end those chromosomes have this structure that we' re talking about, which is the telomeres. What happens that every time one of our cells

replicates, every time na replicates, what it' s going to do is it' s going to cut a little bit of that telomere. That, for example, when a cell ages, because what we see is that these telomeres are shorter. That' s why it' s been so related to aging. I must say that we have a great expert in Spain, a very very expert researcher on telomerase in Spain, who is María Blasco. She also did the thesis, did her doctorate in the laboratory of Dr Orgarita Salas

and is currently the director of the National Research and Oncological Center. I also like this topic because they gave the Nobel to two researchers, Elizabeth Blachond and Carrol Graver, in the two thousand nine to characterize is the telomerase, which was able to lengthen these telomeres and I was lucky enough to meet in person Elizabeth Blackfon in Germany at a meeting that calls for Nobel Prizes in this case of medicine and physiology with young researchers and you a lucky one that will select

me from Spain to go and take a thing that they called as a scientific walk with the Nobel you chose and I chose Elizabeth Blasborn, and the truth is that I thought it was a truly fascinating woman. I mean, it was nice to hear him, to talk about anything, to share with us a lot of experiences and besides, he has a very interesting story, because she also made her doctoral texts with a person who had received two Nobel Prize winners, with Sángel, who is also a little related to things we are

talking about, because he was a person who said his contribution was about sequencing, even the foundations, about sequencing with the method he developed in a laboratory. Then it seems to me like the whole fascinating story. He' s told them a lot about telomena. This already telomerase as the source of eternal youth, that is, if we are able to prevent those telomeres from being shortened by making the lomers super active, because to the various people, then we can get to make those cells immortal. But, as far as I

know, the main problem is that it relates not only to aging, but also to cancer. What this means is that we create a ceuda that is immortal. In the end, what we have is a cell that replicates when we don' t want to. So there has to be a balance, like a very narrow balance between when we want to get a cell not to grow old and, of course, not a disease like this cancer can be compound, just like that. In addition, I remember that during this year

I went a little through Spain, giving good interviewing María Blasco, because, in fact, the one who speaks and the one who tells things is she, who is the one who knows how to listen to her, tell her and just told us this that it is a little that balance that is sought. But let' s go that it has very clear to her and the rest of the community of researchers that it is determining to understand aging and that aging that determinant to understand many of the diseases that we have normalized in our society. That is to say, I believe that in the coming years we will hear a lot about this, since you are talking about coming years.

It turns out that Jattorini already has another question that says that which gene therapies of recent discovery are going to be developed in the latex scale. The question, of course, is a little that you take out the billiard ball we say here always, the ball of villa Laula. About predicting the ball of the future. And that' s hard, but it' s true who better than you who' s an expert on these things than you to tell us that we' re not. It is true that the genes themselves are making tremendous progress and that, in addition, I believe that they are a little hope that we can have to solve some genetic diseases. Does that sound

like a very complicated subject to me? I find it very difficult one of those that I think is more fascinating among those therapies that are done with Chrisper. I' ve never done anything in the lab, but I really like to read about this. And one of the things that you' ve heard from the listeners is that I think it was in December last year, a few months ago, they approved a gene therapy that was based on Chrisper for the zarciform neña, that is, me faciformes is produced or has a genetic mutation in hemogbine, hemolybine. What you' re going to do is join

the oxygen and those erythrocytes. What he' s going to do is transport and that oxygen along the body. I don' t know if you' ve seen the series broadcast other small wood programs. Once the life where the red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red red So, with this therapy

you try to get them not to have that problem or solve this problem. And it has been based on Chrispers that we will surely continue to see next years therapy with Chrisper also from as we talked before, the vaccines that have been made with RNA during the coronavirus, but that we have left you a big push to research with RNA. So I also hope in the next few years there are loved ones thank you that are based on smart. You' re talking about the future and that' s great, because besides that' s what I asked you. I can' t complain about that, but

it' s true that we are very unaware of what is already being done today. There is a lot of thought about these science, fiction, practically what we will achieve and I think we do not recognize, as we should, everything that is already being done today. He asks Gerardo San Cristán what practical benefits these technologies and knowledge have brought us and what they expect in the future. Let' s forget about the future, because you' ve already told us in part, but we' re going to stay a little bit marvelled at those things that you' ve already mentioned in part, but that lead to much more development. Now, I think that, for example, with these technologies that we are talking about DNA amplification, we can get a

lot of future thanks. For example, to improve diagnosis not only to see if, as we did, for example, with PCR during the coronavirus, not only to diagnose a disease, but also to diagnose whether there is a mutation or a genetic problem in a person. We can also even monitor at a certain point how a disease is evolving. So I think that amplification methods are going to continue to be very important in the coming years and will give us many benefits not only in clinical medicine, but in any aspect of research.

Well, then, to wait for him in the future, to enjoy him in the present. And that' s just for a little tip, because it' s true that when you look for applications, you think a lot about doctor, medical application, but when we talk about PCR and you get the DCS saying that you found DNA from a victim or the culprit, you have had to do a PCR through a research on paleogenetics, about the DNA of the Neanderthals that you found in a tooth or the description of a

new species, such as Nisoda' s homo. Well, I don' t remember the scientific name, but Denis the Nisova Oprez, and all that has PCR behind it, too. In the end, the applications are almost infinite. In the end, any of these techniques. What you do is you get from that amount that we said of very small DNA, then amplify it when you were talking, for example, at a crime scene, because if we leave up to a drop of saliva, a hair that has fallen off the killer from very small amounts or even imagine in a robbery or assault

if the victim has even DNA from the aggressor in his nails. From there you can take out this genetic material and then compare it to the possible suspect and see if it was really a very guilty one, that is, that the applications are infinite. I really like what you said about the anthropology part, which I find very beautiful, or to compare our genetic material with that of in man in aardental to see how we seemed to see how it has evolved, which is very beautiful. Even one of the things you do is

go to places where no one has ever been, where you don' t know what there is and take samples, sequence, amplify them, sequence them, then try to identify, for example, new viruses. This has been done by researchers from workplaces who have gone to the avantanti and from there have taken samples and tried to discover new viruses, for example. Then the amplifications are totally infinite, not only in medicines, but in many aspects that may interest us and I have also seen it, for example, for ecological studies,

no longer of viruses, but of which species there are in this environment. I' m going to take a sample of the soil, the water, the air and I' m going to compare it because I find that the same is a bit of genetic material, of real pact, flat, of gift or of lunar cerehuella actually in all the applications that it has are fascinating and I' m going to take advantage to say a non- correction, but note what I said a moment ago because I named the man from Nisoba and I said I don' t remember what the scientific name is. Well for a very good reason, and it seems that the species scientifically in

terms of scientific classification, is indeterminate. So it generated the second part. We don' t know. I think it' s logical that I didn ' t come up with what to call him It' s all right. We have two more questions anyway. I sometimes classify them in a bit peculiar questions, because they are striking and one of them is going to make us dew rosemary that says how feasible is the adn de télice of the film of the fifth element. Here we also like cinema, so why not give room to the question. It is true that I have not seen the film,

but although we always speak feet the structure of the see those or yes, it is true that I have been reading that there are some researchers who, besides having discovered that at a certain moment, there may be a triple elice, continue to investigate about this, because it may have many applications, for example, for pharmacological potential. If we are able, at that particular moment you get to triple elice, but, of course, the reality is that, according to that central dogma of molecular ideology, our genetic material is

double- chain DNA. We have that double propeller, and I don' t think we' re gonna find anyone walking down the street with a triple or something more complicated. I think the most different thing we can find are viruses that don' t have to have double- chain DNA. We all have DNA- sentilla, arm DNA viruses of almost anything we can imagine and because they' re just like that frontier of what we consider alive or not alive. But all the organisms that we say are alive go with chainable DNA.

For the moment, moreover, I suspect that in the fifth element they did not seek to refer to scientific issues. If it didn' t sound good, he takes elements that are usually shown in pairs and put a third. It' s one thing they do in more moments of the movie. I leave it is that there is also an image that is typical. But Paul Renzo asks us another question with which we will close these questions from the public and says always or almost always, the issues about DNA genetics and their repair or modifications are taken with some suspicion and I would even say that they

do not consider them ethically correct. How long do you think this is going to go on, because I think this is slowing down medical and scientific progress. It' s just that we can tell Paul, well, I think it' s not bad that ethics always goes hand in hand with science. I mean, it seems essential to me why, because in the end the end does not justify the means. We must be sure that we are doing things well and, above all, that something we do is not going to have an unexpected consequence. I mean, I think we have to be very

cautious and be sure that we always do things right. I think it' s not bad that ethics goes out of the sea with science. What happens that sometimes seems to go a little faster, potentially what we can do in science about how laws go or how we comment on some ethical aspects. That is, it is important that ethics go quickly, that it accompany science, but of course they always go hand in hand. I don' t think any of it is a taboo to be afraid of or at all. So I mean, I think genetic begetting has brought us indisputable advantages and that this

is going to continue to be so, but of course, always with control and, above all, always respecting, especially when we do things with humans, that is, we can' t make any modification in a person without seeing what consequences that can have later Or if we can alter, for example, an area that we didn' t want to alter a priori, Even when we talk about genetic modifications and we talk about a crop, we also have to take into account if we put that crop in an area outside of a laboratory, how is it going to interact with the rest of species,

or what consequences can that have? That' s why I think it' s good that we always have control and that everything goes hand in hand with ethics and the foresight of what can happen to me. I really like a phrase Marie Curie used to say that nothing in life must be feared, it must only be understood. Now is the time to understand more so that we can have less, that is, than never fear, but always thinking very well what we do and what we want to achieve and regulate it and respecting it, of course, from ethics, because in the end, I think

science is here to serve us and to get things better at no time to hurt us or to do something wrong. Very good message and with that we will finish the questions of the listeners. We' re going to take one last break and we' ll be right back with the final three questions from every nosphere. We' re back to the same old questions. The first one I want to make is which movie you want to recommend to us,

because I must say I wouldn' t dare recommend a movie, because I ' m not especially loving movies. I like live shows much more. I like them better if it was musical, going to the theater or watching a movie show or valet or anything before watching a movie. I also had to say that laboratory doesn' t leave me too much time to watch many movies, but I would like to see a live show more than a particular movie, I wouldn' t dare recommend any, because I recommend not if you

want a musical, since you said about the musicals. Well, I don ' t think I' ve ever seen a musical I didn' t like. I' m sure, well everyone in Madrid has gone to see the lion king or any of those who are now on the billboard who are really spectacular ho, as we sign it up to the lion king or no outsider recommendation. But indeed, it is there. It' s because it' s good. I haven' t gone to watch the watch and see that I' m a fan of musicals, but I haven' t thrown myself yet. I know it has a very powerful choreography, perhaps more emphasis on that than on other aspects of the musical. Well, we signed it up.

Book what book? I want to recommend that I like to read a lot. I think I like reading almost anything more than a book. Maybe I' d recommend an author. I really like Kate Morton' s books, for example, which waits for the public to say a scientific book or some outreach, but in my spare time I like to read almost anything, even if I don' t have it. It' s not science- related, and that' s what it' s all about, besides showing that it' s not all science. Even those who do science have other interests Remember what was Kate Morton' s first book you read. You have

to go back there long in time, some time ago, maybe you wouldn ' t remember it right now. The last one, maybe was one of the last. She was the watchmaker' s daughter and I think there' s another one after that I' ve also read and I' m waiting if she pulls out a new one and I repeat Kate Morton pointed out too and what hobby she wants us to recommend something you say, you must prove it at some point in your life. Well, I think anything you do in your free time eagerly is good as a hobby. I like it a lot in my free time, because my friends, with my family, go

for a walk, have a drink, dance, do sport, almost anything. I think that everything that helps us to disconnect is always good, some sport in particular, because I think that maybe what more sports is dance ah you look, it matters dances of every titector the time. That' s it, so nothing to dance, also to read kid Morton. And, well, if we dance, in the end much the same call us of the rules. That' s how we link up all the alicia. Thank

you so much for coming, thank you very much for your immanation, pleasure a pleasure and we stayed doing a brief reflection, as always that I think I will resume with the one we had already finished, because long ago we have not made a claim here about the limits of science based on ethics that is necessary, it is necessary to remember that science itself is neither bad nor good. It' s about how it turns into apps that have interests, and that' s what we have to take into account. If we develop it with this in mind and we already start from a series of restrictions, it will be more difficult that in time it ends up embezzling in some way,

so why not. Ethics is not here to slow down the advance of science. He' s here to keep him from moving wildly to places where we never wanted him to end up. Thank you so much for listening to us and until the next one.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Noosfera 306 - Un cuento chino | Raúl Ramírez Ruiz

    Nov 20, 20261 hr 18 minAudio

    Cada vez hablamos más sobre China… pero ¿qué sabemos de ella? Mayormente clichés y, aunque Noosfera sea un podcast de ciencia, bien entendida, la historia también tiene cabida en él para arrojar algo de luz sobre el...

    Credit the people on this episode

  2. Noosfera 305 - Cómo observar un fantasma (neutrinos) | Juan Antonio Aguilar Sánchez

    Oct 30, 20261 hr 9 minAudio

    "Alguna vez hemos hablado sobre neutrinos, pero nunca hemos aprovechado una percha de actualidad para hacerlos. Hoy nos centramos en un telescopio congelado, hundido en la Antártida, capaz de detectar las partículas más...

    Credit the people on this episode

  3. Noosfera 304 - Controlar cerebros con luz | Rosario Moratalla

    Oct 23, 20261 hr 17 minAudio

    "La optogenética ha sido galardonada con el Nobel y eso ha despertado entre el público el interés por una tecnología que ya había encandilado a los expertos: una forma de activar e inactivar neuronas a voluntad...

    Credit the people on this episode

  4. Noosfera 303 - La IA y... ¿el fin de la matemática? | Anabel Forte, Roberto Giménez y Miguel Camarasa

    Oct 16, 20261 hr 44 minAudio

    "Algunos lo llaman “mathapocalypse”, pero… ¿Lo es? Open AI dice que su IA ha logrado demostrar uno de los problemas del milenio y otros casi 400 problemas abiertos. Todo ha ocurrido en poco más de un mes y la comunidad...

    Credit the people on this episode

  5. Noosfera 302 - La tierra que pisas | Carmen Castañeda

    Oct 9, 20261 hr 3 minAudio

    "El suelo es más que “tierra”... bueno, es que la tierra también es más que tierra. ¿Cómo se forma a partir de minerales erosionados? ¿Cómo cambia? ¿Cuánto cambia? Es hora de hablar sobre la ciencia de los suelos: la...

    Credit the people on this episode